Global Neurology Devices Market 2024-2028

Description

List of Tables

The neurology devices market is forecasted to grow by USD 7.22 bn during 2023-2028, accelerating at a CAGR of 8.06% during the forecast period. The report on the neurology devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, growing geriatric population, and increasing funding for neurology and related research.

Technavio's neurology devices market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.67%
CAGR	8.06%
Incremental Value	$7.22bn

By End-user

Hospitals
ASCs
Others

By Product

Neurostimulation devices
Interventional neurology devices
Neurosurgery devices
Cerebrospinal fluid management devices
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advances in neurology devices as one of the prime reasons driving the neurology devices market growth during the next few years. Also, increasing number of initiatives supporting research related to neurostimulation technology and growing medical tourism in emerging economies will lead to sizable demand in the market.

The report on the neurology devices market covers the following areas:

Neurology devices market sizing
Neurology devices market forecast
Neurology devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices market vendors that include Abbott Laboratories, Allengers Medical Systems Ltd., Becton Dickinson and Company, Boston Scientific Corporation, Cadence Inc., Helius Medical Technologies Inc., Hospital Equipment Manufacturing Co., Integra Lifesciences Corp., Johnson and Johnson Services Inc., LivaNova PLC, Medtronic, MicroPort Scientific Corp., Natus Medical Incorporated, NeuroPace Inc., Nihon Kohden Corp., Stryker Corp., The Magstim Co. Ltd., Zimmer Biomet Holdings Inc., B.Braun SE, Penumbra Inc., and Rapid Medical Ltd.. Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40120

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global neurology devices market 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Product Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by End-user

6.1 Market segments
6.2 Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
6.4 ASCs - Market size and forecast 2023-2028
6.5 Others - Market size and forecast 2023-2028
6.6 Market opportunity by End-user

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Neurostimulation devices - Market size and forecast 2023-2028
7.4 Interventional neurology devices - Market size and forecast 2023-2028
7.5 Neurosurgery devices - Market size and forecast 2023-2028
7.6 Cerebrospinal fluid management devices - Market size and forecast 2023-2028
7.7 Others - Market size and forecast 2023-2028
7.8 Market opportunity by Product

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 Japan - Market size and forecast 2023-2028
9.11 China - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 B.Braun SE
12.5 Becton Dickinson and Company
12.6 Boston Scientific Corporation
12.7 Cadence Inc.
12.8 Integra Lifesciences Corp.
12.9 Johnson and Johnson Services Inc.
12.10 LivaNova PLC
12.11 Medtronic
12.12 MicroPort Scientific Corp.
12.13 Natus Medical Incorporated
12.14 Nihon Kohden Corp.
12.15 Penumbra Inc.
12.16 Stryker Corp.
12.17 Zimmer Biomet Holdings Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations